OLR1 and nasopharyngeal carcinoma: To confirm the immunosuppressive capacity of LOX-1+ PMN-MDSCs in NPC survivors with CHB, T cells and LOX-1+ PMN-MDSCs from NPC survivors with CHB were purified from whole blood using flow sorting, with cells from patients with CHB as controls.